1. We Deliver More ™
Changing India’s biotech landscape by
developing tools for the life sciences and agri
industry
D & B / SMERA Rated

2. We are a single owner firm established in 2003, located in the
commercial hub of India – Mumbai or erstwhile Bombay.
KRISHGEN today operates in the broad segments of medical
diagnostics, drug discovery research, biopharmaceuticals and plant /
food sciences.
The compounded average growth in the past three years has been 74%
p.a. KRISHGEN gross revenues as of 2011 were USD5,0 million.
A KRISHGEN PRESENTATION © 2011

3. HOW TO USE THIS GUIDE:
About KRISHGEN
Targeting the research and diagnostics markets, our goal is to enable
breakthroughs in biological research, diagnostics, drug discovery and
the treatment of disease. We enjoy a dominant position in the provision
of immunoassay kits, supply of primary human cells and cell
lines, glycobiology and preclinical toxicology tools.
KRISHGEN takes a highly collaborative approach to business
relationships with its customers and partners. We are committed to
providing our customers with world-class solutions, service and support.
Our track record of delivering innovative new products, by distribution
arrangements with leading companies worldwide or the judicious
interface with the academia has given us the broadest range of products
available. The strength lies in our ability to understand technologies and
support the scientists with technical backup and strong logistics.
A KRISHGEN PRESENTATION © 2011

4. About KRISHGEN
KRISHGEN meets the needs of its pharmaceutical and clinical
customers by providing a range of Research Use Only kits for
researchers in drug development and pre-clinical studies, and in offering
fully-optimized and validated products for ensuing preclinical and clinical
studies.
KRISHGEN’s recently released cytokine ELISA kits are an innovative
cost effective tool for disease research, drug discovery &
development, and molecular diagnostic test development.
KRISHGEN is funded privately through its owners and private investors.
It is a non-listed, non-traded SME, rated by Dun & Bradstreet / SMERA
(SME Rating Agency of India).
Our DUNS Number is 65-039-6034.
A KRISHGEN PRESENTATION © 2011

5. Our History
To support it's plans, Krishgen initially focused on developing marketing
and distribution support for diagnostics.
2004.. First Partner for distribution tied-up with Medipan GmbH / Generic Assays
GmbH in Germany.
2005 .. the research and life sciences products were introduced with its arrangements
with leading US & European companies.
2006 .. the Glycobiology line was introduced in October for distribution.
2007 .. the tools for preclinical toxicology were introduced in August.
2008 .. Promocell GmbH, Germany distribution started in India. Its own products under
the KRISHGEN label were manufactured and introduced in October. Krishgen started
offering immunoassay development services in Nov 2008.
2009 .. KRIBIOLISA bioprocess ELISA kits launched.
2010 .. KRISHILISA GMO ELISA kits and Gold Ring Cytokine ELISAs launched.
2011 .. International distribution efforts started.
KRISHGEN's product and service are now used by respected
academic, biotech, pharmaceutical and government laboratories in India
and worldwide.
A KRISHGEN PRESENTATION © 2011

6. KRISHGEN BIOSYSTEMS
– Group Holding Proprietary Company
Revenues* 2011 USD 5,0million
Focuses on diagnostics, drug discovery
research, plant / agri sciences
and food safety
Kodon Sciences
KRISHTECH Solutions
(India)
Kodon Sciences (India) – focuses on plant sciences and food safety assays.
Established in 2008.
KRISHTECH Solutions – focuses on biopharmaceutical and vaccine
manufacturing companies. Established in 2009.
A KRISHGEN PRESENTATION © 2011

7. Advisory Team
Raman Jain, MSc (Northwestern University, US)
Over 38 years experience in healthcare industry. Previously Managing Director, Nirlac Chemicals and
then Fortex Remedies Pvt Ltd, contract manufacturer of sterile pharmaceuticals. Member : Indian
Pharmaceutical Association. Founder Member Indian Drug (Pharmaceutical) Manufacturers Association
Kawar Prashant Govindrao
Scientist (PMB), Molecular Biology & Genetic Engineering Lab., Vasantdada Sugar Institute, Pune
Dr I Khatkhatay
Senior Scientist, National Institute For Research in Reproductive Health, Mumbai
Dr Meena Desai
Scientist, National Institute For Research in Reproductive Health, Mumbai
Aditya Jain, MBA (Drexel University, USA)
Vice President, LaReina Collection, Los Angeles, USA.
A KRISHGEN PRESENTATION © 2011

8. Investors / Source of Funds
 Bank Of India
 Owner’s Seed Capital
Private Investors :
 Veerchand Manawat Family
 Kalpesh Jain HUF
A KRISHGEN PRESENTATION © 2011

9. Business Concept
KRISHGEN believes in professionalism. Right from choosing principals
which we have done with great care to our sales channel partners or
our marketing team we have applied one principle – the approach and
professionalism of the entity to the job at hand.
We believe that a systematic approach and focus to the job will ensure
that all set targets and goals are achieved.
No fancy management jargons but a simple approach of doing the job
given sincerely and keeping the customer happy. Our philosophy – We
Deliver More – encompasses all that we believe in.
A KRISHGEN PRESENTATION © 2011

10. Our Sales Network
We currently hold distribution rights for sales in South East Asia as well
as in countries including
Singapore, Malaysia, Thailand, Vietnam, Philippines for a number of
our principal companies.
Our focus the past few years has been in India which is our principal
market and the major revenue earner.
We reach the entire Indian region with our own employee based
marketing field team supported by our product executives and
application specialists.
KRISHGEN also now has a network of distributors all across the world
for its own manufactured / branded products. It also supplies on OEM
labeling to leading US and Canadian based companies.
A KRISHGEN PRESENTATION © 2011

11. Technical Sales & Marketing Support
 Regular Literatures and mailing on specific products and applications.
(we use Constant Contact email marketing tool)
 CD presentations on Product Category Focus
 Training of Technicians / Users at our application laboratory
 Participation in Trade Shows, Conferences, Exhibitions
 Conducting Roadshows
A KRISHGEN PRESENTATION © 2011

12. Resources Library
We have the largest resources library for marketing our products in
terms of flyers, catalogs, brochures, technical series mails etc. Our in-
house print shop has capacity to print and mail over 10,000 copies per
month which we use in conjunction with our database.
Promotions & Offers
We conduct regular promotions and seasonal offers to boost sales and
highlight products.
A KRISHGEN PRESENTATION © 2011

13. Markets and Achievements
KRISHGEN today holds over 80% of the market for biopharmaceuticals with its
glycosylation tools working with world’s leading companies.
With our focus on costs and services, we are a `strategic vendor’ and ‘preferred
partner’ to a number of leading biopharma and vaccine companies.
We were the first movers to market exclusively Invitrogen’s primary human cell
cultures and medias (erstwhile Cascade Biologics)in India from 2004 till 2008
when Invitrogen Corporation, USA set up it’s own subsidiary in India.
We hold over 74% market share for the ADME Tox in India with our nearest
competitor being BD Biosciences and Invitrogen.
We are the market leaders in India for Vitamin D assays for medical diagnostics
and for immunoassay tools for diabetes research and clinical studies.
We have developed and now market exclusively our own manufactured
bioprocess contamination kits for the Indian biopharmaceutical sector as well as
a host of products.
A KRISHGEN PRESENTATION © 2011

14. Our Certifications
We are registered with our
Food & Drug Administration
Ministry of Animal Husbandry
Ministry of Health & Family Welfare
Director-General of Foreign Trade
Dun & Bradstreet / SMERA
Our Association Memberships
Member – Indian Merchant Chambers
Member – Indo German Chamber of Commerce
Member – Association of Biotechnology Led Enterprises
Member - National Seed Association of India
A KRISHGEN PRESENTATION © 2011

15. Scientific Presentations
Posters Presented -
2009 Immunocon, Bangalore
Development and validation of a generic E.coli HCP ELISA for determination of host cell
proteins for biopharmaceuticals expressed in E.coli
2010 Bangalore India Bio, Bangalore
Development and validation of cost effective assay for Development and validation of
ELISA for qualitative assessment of Cry 2Ab protein in Bt Cotton
Development and analytical validation of a generic ELISA kit for measurement of Host Cell
Proteins in Chinese Hamster Ovary cells.
Use of indigenous ELISA for estimation of cytokines and estradiol levels in women
A KRISHGEN PRESENTATION © 2011

16. A KRISHGEN PRESENTATION © 2011

17. Our 3 E’s of Business
which has enabled us to
make KRISHGEN, India’s
leading biotech company
with products presence in Enthusiasm
major markets across the
world.
Enterprise
Energy
A KRISHGEN PRESENTATION © 2011

18. Partner us in your efforts to market and
sell your products leveraging our
capabilities in one of Asia’s largest
market.
Talk to us to work together to increase
the reach of our products.
We would be happy to connect –
email : sales_usa@krishgen.com
info@krishgen.com
Tel: +1-213-2913096 (US)
+91-22-66372990 (India)
Fax: +1-213-4022025 (US)
+91-22-66372991 (India)
A KRISHGEN PRESENTATION © 2011